Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review
Li, Ning, Huang, Hui-Yao, Wu, Da-Wei, Yang, Zhi-Min, Wang, Jun, Wang, Jian-Sheng, Wang, Shu-Hang, Fang, Hong, Yu, Yue, Bai, Ying, Yan, Zhao, Cao, Ye, Jiang, Min, Liu, Yan-Fei, Li, Kun-Yan, Xu, Bing-He, Sun, Yan, He, Jie
Published in The lancet oncology (01.11.2019)
Published in The lancet oncology (01.11.2019)
Get full text
Journal Article
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
Hu, Xi-Chun, Prof, Zhang, Jian, MD, Xu, Bing-He, Prof, Cai, Li, Prof, Ragaz, Joseph, Prof, Wang, Zhong-Hua, MD, Wang, Bi-Yun, MD, Teng, Yue-E, Prof, Tong, Zhong-Sheng, Prof, Pan, Yue-Yin, Prof, Yin, Yong-Mei, Prof, Wu, Chang-Ping, Prof, Jiang, Ze-Fei, Prof, Wang, Xiao-Jia, Prof, Lou, Gu-Yin, MD, Liu, Dong-Geng, MD, Feng, Ji-Feng, Prof, Luo, Jian-Feng, PhD, Sun, Kang, PhD, Gu, Ya-Jia, Prof, Wu, Jiong, Prof, Shao, Zhi-Min, Prof
Published in The lancet oncology (01.04.2015)
Published in The lancet oncology (01.04.2015)
Get full text
Journal Article
Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study
Yi, Zong‐Bi, Yu, Pei, Zhang, Su, Wang, Wen‐Na, Han, Yi‐Qun, Ouyang, Qu‐Chang, Yan, Min, Wang, Xiao‐Jia, Hu, Xi‐Chun, Jiang, Ze‐Fei, Huang, Tao, Tong, Zhong‐Sheng, Wang, Shu‐Sen, Yin, Yong‐Mei, Li, Hui, Yang, Run‐Xiang, Yang, Hua‐Wei, Teng, Yue‐E, Sun, Tao, Cai, Li, Li, Hong‐Yuan, Chen, Xi, He, Jian‐Jun, Liu, Xin‐Lan, Yang, Shun‐E, Wang, Jia‐Yu, Fan, Jin‐Hu, Qiao, You‐Lin, Xu, Bing‐He
Published in International journal of cancer (01.02.2021)
Published in International journal of cancer (01.02.2021)
Get full text
Journal Article
Clinical development of immuno-oncology in China
Wu, Da-Wei, Huang, Hui-Yao, Tang, Yu, Zhao, Yang, Yang, Zhi-Min, Wang, Jun, Wang, Shu-Hang, Yu, Yue, Fang, Yuan, Fang, Hong, Bai, Ying, Sun, Chao, Fan, Qi, Yu, An-Qi, Wang, Huan-Ling, Du, Chun-Xia, Chen, Kun, Huang, Ming-De, Zhang, Yin, Li, Ning, Xu, Bing-He, Sun, Yan, He, Jie
Published in The lancet oncology (01.08.2020)
Published in The lancet oncology (01.08.2020)
Get full text
Journal Article
Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy
Wang, Chen-yu, Sheng, Chang-cheng, Ma, Guang-li, Xu, Da, Liu, Xiao-qin, Wang, Yu-ya, Zhang, Li, Cui, Chuan-liang, Xu, Bing-he, Song, Yu-qin, Zhu, Jun, Jiao, Zheng
Published in Acta pharmacologica Sinica (01.08.2021)
Published in Acta pharmacologica Sinica (01.08.2021)
Get full text
Journal Article
Availability of anticancer biosimilars in 40 countries
Huang, Hui-Yao, Wu, Da-Wei, Ma, Fei, Liu, Zhi-Lei, Shi, Ju-Fang, Chen, Xia, Wang, Shu-Hang, Fang, Hong, Bai, Ying, Yu, Yue, Fang, Yuan, Sun, Chao, Fan, Qi, Wu, Ying, Fan, Rui-Hua, Zhou, Cai-Yun, He, Bao-Xia, Dai, Min, Li, Ning, Xu, Bing-He, Sun, Yan, He, Jie
Published in The lancet oncology (01.02.2020)
Published in The lancet oncology (01.02.2020)
Get full text
Journal Article
Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study
Kang, Yi‐Kun, Si, Yi‐Ran, Ju, Jie, Jia, Zhu‐Qing, Hu, Nan‐Lin, Dong, Hao, Wang, Xue, Yue, Jian, Jiang, Pei‐Di, Li, Zhao‐Liang, Zhang, Yun‐Yun, Wang, Yan, Xu, Bing‐He, Yuan, Peng
Published in Cancer medicine (Malden, MA) (01.03.2023)
Published in Cancer medicine (Malden, MA) (01.03.2023)
Get full text
Journal Article
Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity
Li, Chun-Xiao, Wang, Jin-Song, Wang, Wen-Na, Xu, Dong-Kui, Zhou, Yan-Tong, Sun, Fang-Zhou, Li, Yi-Qun, Guo, Feng-Zhu, Ma, Jia-Lu, Zhang, Xue-Yan, Chang, Meng-Jiao, Xu, Bing-He, Ma, Fei, Qian, Hai-Li
Published in Military medical research (19.12.2022)
Published in Military medical research (19.12.2022)
Get full text
Journal Article
Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China
Si, Yi-Ran, Du, Feng, Hu, Nan-Lin, Wang, Xue, Yue, Jian, Jiang, Pei-Di, Xu, Bing-He, Yuan, Peng
Published in Chinese medical journal (05.03.2021)
Published in Chinese medical journal (05.03.2021)
Get full text
Journal Article
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
Fan, Jin-Hu, Zhang, Su, Yang, Huan, Yi, Zong-Bi, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E, Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E, Wang, Jia-Yu, Xu, Bing-He, Qiao, You-Lin
Published in Frontiers in oncology (25.01.2023)
Published in Frontiers in oncology (25.01.2023)
Get full text
Journal Article
Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative,metastatic breast cancer
Chen, Xue‐Lian, Du, Feng, Hong, Ruo‐Xi, Wang, Jia‐Yu, Luo, Yang, Li, Qing, Fan, Ying, Xu, Bing‐He
Published in Ai zheng (25.04.2016)
Published in Ai zheng (25.04.2016)
Get full text
Journal Article
Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial
Li, Jian-Wei, Liu, Guang-Yu, Ji, Ya-Jie, Yan, Xia, Pang, Da, Jiang, Ze-Fei, Chen, De-Dian, Zhang, Bin, Xu, Bing-He, Shao, Zhi-Ming
Published in Cancer management and research (01.01.2019)
Published in Cancer management and research (01.01.2019)
Get full text
Journal Article
Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China
Han, Yi-Qun, Yi, Zong-Bi, Yu, Pei, Wang, Wen-Na, Ouyang, Qu-Chang, Yan, Min, Wang, Xiao-Jia, Hu, Xi-Chun, Jiang, Ze-Fei, Huang, Tao, Tong, Zhong-Sheng, Wang, Shu-Sen, Yin, Yong-Mei, Li, Hui, Yang, Run-Xiang, Yang, Hua-Wei, Teng, Yue-E., Sun, Tao, Cai, Li, Li, Hong-Yuan, Ouyang, Xue-Nong, He, Jian-Jun, Liu, Xin-Lan, Yang, Shun-E., Qiao, You-Lin, Fan, Jin-Hu, Wang, Jia-Yu, Xu, Bing-He
Published in Journal of oncology (2021)
Published in Journal of oncology (2021)
Get full text
Journal Article
Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer
Zhang, Bai-Lin, Sun, Tong, Zhang, Bao-Ning, Zheng, Shan, Lü, Ning, Xu, Bing-He, Wang, Xiang, Chen, Guo-Ji, Yu, Dian-Ke, Lin, Dong-Xin
Published in Chinese medical journal (01.01.2011)
Published in Chinese medical journal (01.01.2011)
Get full text
Journal Article
Oral etoposide monotherapy is effective for metastatic breast cancer with heavy prior therapy
Yuan, Peng, Xu, Bing-he, Wang, Jia-yu, Ma, Fei, Fan, Ying, Li, Qing, Zhang, Pin
Published in Chinese medical journal (01.03.2012)
Published in Chinese medical journal (01.03.2012)
Get full text
Journal Article
Effect of Hormone Therapy on Long-term Outcomes of Patients with Human Epidermal Growth Factor Receptor 2-and Hormone Receptor-Positive Metastatic Breast Cancer: Real World Experience in China
Du, Feng, Yuan, Peng, Wang, Jia-Yu, Ma, Fei, Fan, Ying, Luo, Yang, Xu, Bing-He
Published in Asian Pacific journal of cancer prevention : APJCP (2015)
Get full text
Published in Asian Pacific journal of cancer prevention : APJCP (2015)
Journal Article
Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up
Gao, Song-lin, Wang, Ding-yuan, Wang, Xi, Zhang, Bo, Du, Feng, Ju, Jie, Yue, Jian, Kang, Yi-kun, Wang, Xue, Xu, Bing-he, Yuan, Peng
Published in Breast cancer research and treatment (01.02.2023)
Published in Breast cancer research and treatment (01.02.2023)
Get full text
Journal Article
Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer
Ju, Jie, Du, Feng, Gao, Song-Lin, Si, Yi-Ran, Hu, Nan-Lin, Liu, Dong-Xu, Wang, Xue, Yue, Jian, Zheng, Fang-Chao, Kang, Yi-Kun, Yang, Zi-Xuan, Ma, Fei, Xu, Bing-He, Yuan, Peng
Published in Breast cancer research and treatment (01.07.2022)
Published in Breast cancer research and treatment (01.07.2022)
Get full text
Journal Article
Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study
Xu, Bing-he, Jiang, Ze-fei, Shen, Zhen-zhou, Guan, Zhong-zhen, Chen, Zheng-dong, Cheng, Ying, Zheng, Hong, Jiang, Jun, Wang, Xiao-jia, Tong, Zhong-sheng, Qin, Shu-kui, Luo, Yi, Yao, Min, Wang, Li-wei, He, Jing
Published in Chinese medical journal (01.03.2012)
Published in Chinese medical journal (01.03.2012)
Get full text
Journal Article
Neoadjuvant Combination Chemotherapy with Pegylated Liposomal Doxorubicin and Vinorelbine for Locally Advanced Breast Cancer
Shen, Zhen-zhou, Shao, Zhi-min, Xu, Bing-he, Wang, Ling, Wang, Yong-sheng, Liu, Jian, He, Ping-qing, Su, Feng-xi, Jiang, Ze-fei, Zhang, Bin, Li, Lian-fang
Published in Cancer biology & medicine (01.02.2010)
Published in Cancer biology & medicine (01.02.2010)
Get full text
Journal Article